Skip to content

Clinical trials

Completed Phase 2 Glucose Metabolism Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Phase: Phase 2 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20072
20083
20093
20102
20132
20142
20151
20162
20172
20182
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda5
Albert Einstein College of Medicine2
Johnny Ludvigsson2
Akcea Therapeutics1
Calibra Medical, Inc.1
Diamyd Medical AB1
Eli Lilly and Company1
Genfit1
Institut National de la Santé Et de la Recherche Médicale, France1
King Abdulaziz University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders25
Diabetes Mellitus19
Diabetes Mellitus, Type 213
Metabolic Diseases13
Endocrine System Diseases9
Dyslipidemias5
Diabetes Mellitus, Lipoatrophic4
Diabetes Mellitus, Type 14
Insulin Resistance4
Autoimmune Diseases3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.